Bayesian Capital Management’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-12,400
Closed -$3.9M 749
2025
Q2
$3.9M Buy
+12,400
New +$3.58M 0.62% 33
2025
Q1
Sell
-7,932
Closed -$2.07M 889
2024
Q4
$2.07M Buy
+7,932
New +$2M 0.25% 120
2024
Q3
Sell
-3,300
Closed -$666K 969
2024
Q2
$666K Buy
+3,300
New +$595K 0.08% 306
2023
Q3
Sell
-1,332
Closed -$384K 923
2023
Q2
$384K Sell
1,332
-10,832
-89% -$3.29M 0.04% 466
2023
Q1
$3.88M Buy
12,164
+7,600
+167% +$2.25M 0.48% 46
2022
Q4
$1.34M Buy
+4,564
New +$1.26M 0.2% 122
2020
Q2
Sell
-2,090
Closed -$346K 726
2020
Q1
$346K Sell
2,090
-16,523
-89% -$3.02M 0.07% 406
2019
Q4
$3.19M Buy
18,613
+11,000
+144% +$1.83M 0.54% 29
2019
Q3
$1.26M Buy
7,613
+4,669
+159% +$656K 0.24% 107
2019
Q2
$351K Buy
+2,944
New +$302K 0.07% 333
2018
Q3
Sell
-4,531
Closed -$388K 762
2018
Q2
$388K Buy
+4,531
New +$406K 0.09% 329
2018
Q1
Sell
-13,000
Closed -$897K 769
2017
Q4
$897K Buy
13,000
+3,800
+41% +$249K 0.18% 188
2017
Q3
$507K Buy
+9,200
New +$502K 0.12% 261
2017
Q1
Sell
-20,902
Closed -$788K 641
2016
Q4
$788K Buy
20,902
+12,802
+158% +$477K 0.2% 193
2016
Q3
$332K Sell
8,100
-1,100
-12% -$43.5K 0.22% 169
2016
Q2
$278K Buy
9,200
+2,100
+30% +$65.3K 0.17% 251
2016
Q1
$235K Sell
7,100
-900
-11% -$28.3K 0.22% 232
2015
Q4
$302K Buy
+8,000
New +$269K 0.43% 98

Other funds holding PODD

Bayesian Capital Management's PODD Position: Q3 2025 in Review

Bayesian Capital Management sold out of Insulet (PODD) in Q3 2025, closing a stake of 12,400 shares — an estimated $3.9M sold.

Bayesian Capital Management first reported a position in PODD in Q4 2015 and held it in 18 quarters. The position peaked at $3.9M in Q2 2025. 813 funds tracked by Wall St. Rank hold PODD as of Q3 2025.

  • Bayesian Capital Management reported no remaining Insulet position as of Q3 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 12,400 Insulet shares in Q3 2025, an estimated $3.9M.
  • Bayesian Capital Management first reported a position in Insulet in Q4 2015 and held it in 18 quarters.
  • Bayesian Capital Management's Insulet position peaked at $3.9M in Q2 2025.
  • 813 funds tracked by Wall St. Rank held Insulet as of Q3 2025.

Based on Bayesian Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.